Investment Rating - The investment rating for the report is "Accumulate (Maintain)" [1] Core Viewpoints - The report highlights that the company has shown robust revenue growth, with a 2025 revenue of 739 million yuan, representing a year-on-year increase of 19.91%. However, the net profit attributable to the parent company decreased by 23.05% to 67 million yuan due to cost pressures [6][10] - The company is focusing on expanding its market presence in Southeast Asia and gradually entering the European and American markets, with projected revenues of 905 million yuan in 2026, growing at a rate of 22.37% [10] - The report emphasizes the increasing market concentration in the konjac product sector, with the company expected to maintain a market share of around 12% in the konjac gel category in 2024, indicating potential for further growth [10] Summary by Relevant Sections Financial Performance - In 2025, the company achieved total revenue of 739 million yuan, with a growth rate of 19.91%. The net profit attributable to the parent company was 67 million yuan, down 23.05% year-on-year [6][10] - The company’s gross margin for 2025 was 19.99%, a decrease of 6.66 percentage points, while the net margin was 9.03%, down 5.03 percentage points [10] - The projected revenues for 2026-2028 are 905 million yuan, 1.087 billion yuan, and 1.268 billion yuan, respectively, with growth rates of 22.37%, 20.17%, and 16.65% [10] Market and Product Insights - The company’s product segments include konjac powder, konjac food, and konjac beauty products, with revenues of 515 million yuan, 213 million yuan, and 3 million yuan, respectively, showing year-on-year growth of 18.74%, 24.38%, and a decline of 37.71% [10] - The company is shifting focus to low-calorie meal replacement foods, plant-based innovations, and tea ingredient markets, while maintaining a strong B2B business model [10] - The company plans to enhance its brand "Molege" through online and local tourism channels, as well as offline distributors [10] Valuation and Investment Recommendations - The current market valuation corresponds to a price-to-earnings ratio (P/E) of 25.9 for 2026, 19.5 for 2027, and 15.9 for 2028, suggesting a favorable investment outlook [10] - The report maintains an "Accumulate" rating based on the anticipated growth in revenue and profitability, despite the recent decline in net profit [10]

消费行业研究组 执业证书编号：S1410525120001 % 1 个月 3 个月 12 个月 相对收益 -7.11 -21.67 -0.59 绝对收益 -24.39 -34.77 -3.28 相关研究报告 | 投资评级： | 增持（维持） | | --- | --- | | 当前价格: | 21.82元 | 证券研究报告·公司点评报告 2026 年 3 月 30 日 江海证券研究发展部 | 总股本(百万股) | | | 103.17 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | A 股股本(百万股) | | | 103.17 | | | | | | | B/H 股股本(百万股) | | | -/- | | | | | | | A 股流通比例(%) | | | 66.56 | | | | | | | 个月最高/最低(元) | | | 84.00/21.02 | | 12 | | | | | 第一大股东 | | | 吴平 | | | | | | | 第一大股东持股比例(%) | | | 26.58 | | | | | ...